Observe Medical ASA (DE:OM5A) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Observe Medical ASA reported a positive first half of 2024 with growth in operating revenues to NOK 13.1 million, driven by increased UnoMeterT sales. The company also successfully launched the UnoMeterT Safeti Plus, contributing to their strategic and commercial progress, and plans to further enhance their product line with upcoming releases. Additionally, Observe Medical strengthened its financial position through a private placement of new shares raising NOK 22 million.
For further insights into DE:OM5A stock, check out TipRanks’ Stock Analysis page.